| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |